Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott from JPMorgan. And it's my pleasure to be introducing Teva today at the JPMorgan Healthcare Conference. From the company, we have the CEO, Richard Francis. And Richard joined Teva, I guess, about two years ago and it's been a very productive couple of years, great stock performance. And looking forward to hearing from Richard in terms of Teva going forward and the outlook from here. So with that, over to Richard.
Thank you, Chris. Great to be here at JPMorgan. Thank you for hosting us, Chris. Looking forward to the questions afterwards. I'm going to take a bit of time just to go through some slides, maybe to help the discussion later.
But I think what I want to start with is maybe highlight the fact that when I came here two years ago, it was a very different discussion and narrative around Teva. And I want to say that I'm particularly proud of all the Teva employees around the world who
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
